Skip to main content
Caplight Logo









Leash Bio

Leash Bio

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.leash.bio/

Last Round

Seed

Apr 5, 2024

Total Funding Raised

$9.3M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Leash Bio is a biotechnology company that develops machine learning models for medicinal chemistry by generating large-scale empirical datasets of protein-small molecule interactions.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Synthetic Data

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

drug discoveryDNA-encoded libraryDELhigh-throughput screeningcomputational drug designsmall molecule interactionAI drug discoveryin silico drug discoveryprotein-ligand bindingmachine learning datasetsdata as a serviceDaaShit-to-leadbiotech R&Dmedicinal chemistry AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leash Bio Comparables

Compare Leash Bio with similar companies based on industry and business-model similarity.

Leash Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anagenex
83%
Orogen Therapeutics
79%
Relay Therapeutics
76%

Leash Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 5, 2024

Key People

Founding team and executive leadership

Andrew Blevins

CTO and co-founder

Founding Team

Ian Quigley

Co-Founder, CEO

Founding Team

Leash Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 33% MoM.

  • Apr 5, 2024

    $9.3M round led by SpringTide Ventures.

Leash Bio Filings

Explore SEC and related filing metadata, where available.

Leash Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Leash Bio's valuation, stock price, and market status.

Is Leash Bio a public or private company?

Leash Bio is a private company.

What is the current stock price of Leash Bio?

Leash Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Leash Bio worth (valuation)?

Valuation information for Leash Bio is not publicly available.

Can I buy Leash Bio stock?

Leash Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Leash Bio's last funding round?

Leash Bio's most recent funding round was Seed on April 5, 2024.

Who are the main investors in Leash Bio?

Key investors in Leash Bio include SpringTide Ventures.

Will Leash Bio IPO soon?

No public IPO plans have been announced for Leash Bio.

How can I track Leash Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leash Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range14
Year Founded2021
Last FundingApr 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?